1-4 of 4
Bernadette O'Donoghue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Understanding the Collateral Damage of Treating Acute Myeloid Leukemia: An Estimate of Patient-Reported Side Effect Rates from a National Survey

Norah Crossnohere, MPH, Daniel R. Richardson, MD MA, B. Douglas Smith, MD, Crystal Reinhart, Bernadette O'Donoghue, Susan Love, MD MBA, John F.P. Bridges, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3573.
https://doi.org/10.1182/blood-2018-99-116931
Published: 2018
Journal Articles

Patients with AML Worry about More Than Just Dying: Quantifying Patient Experience Using Best-Worst Scaling

Daniel R. Richardson, MD MA, Allison H. Oakes, Gary Rathsmill, Crystal Reinhart, Bernadette O'Donoghue, John F.P. Bridges, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 717.
https://doi.org/10.1182/blood-2018-99-116669
Published: 2018
Journal Articles

Quantifying Patient Preferences for Treatment Outcomes in AML: A Discrete-Choice Experiment

Daniel R. Richardson, MD MA, Jaein Seo, PharmD, B. Douglas Smith, MD, Elihu H. Estey, MD, Bernadette O'Donoghue, John F.P. Bridges, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 718.
https://doi.org/10.1182/blood-2018-99-113071
Published: 2018
Journal Articles

Assessing Patient Preferences for the Benefits and Risks of Treating for Acute Myeloid Leukemia (AML): A Pilot Study

Jaein Seo, PharmD, MHS, B. Douglas Smith, MD, Elihu H. Estey, MD, Ernest S. Voyard, Jr., JD, Bernadette O'Donoghue, MPhil, John F. P. Bridges, PhD
Journal: Blood
Blood (2016) 128 (22): 4799.
https://doi.org/10.1182/blood.V128.22.4799.4799
Published: 2016